Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 05/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 33.74 11.89 1.67 17.11 11.36
Fund with Sales Charge (%) (POP) 26.38 9.80 0.53 16.45 11.08
NASDAQ Biotechnology Index (%) 34.73 12.23 2.05 17.70 12.01
S&P 500 Index (%) 12.84 10.23 9.86 13.15 7.42
Quarter EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -1.10 1.58 -2.02 13.30 10.34
Fund with Sales Charge (%) (POP) -6.54 -0.32 -3.12 12.66 10.07
NASDAQ Biotechnology Index (%) -3.42 3.39 -1.17 13.82 11.02
S&P 500 Index (%) -6.98 5.10 6.72 10.53 6.69

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund without Sales Charge (%) (NAV) 34.84 -15.72 18.80 -17.16 5.50 33.91 68.64 29.35 8.35 17.28
Fund with Sales Charge (%) (POP) 27.43 -20.35 11.97 -21.92 -0.57 26.22 58.95 21.90 2.12 10.54
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06

Cumulative Total Returns [further-information] As of 03/31/2020

Month EndAs of 05/31/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 9.55 33.74 40.09 8.66 385.34 1,050.11
Fund with Sales Charge (%) (POP) 3.53 26.38 32.38 2.68 358.62 986.66
NASDAQ Biotechnology Index (%) 11.70 34.73 41.38 10.67 410.17 1,214.88
S&P 500 Index (%) -4.97 12.84 33.95 60.05 244.08 408.29
Quarter EndAs of 03/31/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.44 -1.10 4.80 -9.68 248.68 819.27
Fund with Sales Charge (%) (POP) -17.25 -6.54 -0.96 -14.65 229.48 768.55
NASDAQ Biotechnology Index (%) -10.41 -3.42 10.52 -5.70 265.12 954.58
S&P 500 Index (%) -19.60 -6.98 16.11 38.47 172.10 330.05

After-Tax Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 05/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 31.01 10.48 0.18 15.63
Fund without Sales Charge (%) (NAV) After Shares Sold 21.61 8.96 0.90 14.10
Fund with Sales Charge (%) (POP) Before Shares Sold 23.80 8.41 -0.95 14.98
Fund with Sales Charge (%) (POP) After Shares Sold 17.17 7.31 0.03 13.50
Quarter EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -3.11 0.28 -3.46 11.87
Fund without Sales Charge (%) (NAV) After Shares Sold 1.17 1.18 -1.67 10.85
Fund with Sales Charge (%) (POP) Before Shares Sold -8.45 -1.59 -4.54 11.24
Fund with Sales Charge (%) (POP) After Shares Sold -2.15 -0.27 -2.49 10.28

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.04%
Net Expense Ratio [further-information] 1.02%
Max Initial Sales Charge 5.50%
CDSC 1.00%

Volatility Measures [further-information] As of 06/30/2020 Updated Monthly, based on a 3-year period

Beta 1.03
Sharpe Ratio 0.34
Standard Deviation 23.76

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index